期刊文献+

血清循环 Bmi-1 mRNA 检测方法的建立及其在结直肠癌诊断中的应用 被引量:5

Establishment of detection method for serum circulating Bmi-1 mRNA and its application in diagnosis of colorectal cancer
原文传递
导出
摘要 目的:建立一种血清循环B细胞特异性莫洛尼白血病毒插入位点1( Bmi-1)信使核糖核酸(mRNA)直接逆转录-实时荧光定量聚合酶链反应(RT-qPCR-D)检测方法,并运用该方法对结直肠癌血清循环Bmi-1 mRNA水平进行分析,探讨其在结直肠癌诊断中的价值。方法方法学建立。提取结直肠癌HT29细胞株RNA,建立Bmi-1、泛素C ( UBC)、甘油醛-3-磷酸脱氢酶( GAPDH) mRNAs检测标准曲线,计算扩增效率。利用RT-qPCR-D方法对血清、准备液混合液中Bmi-1 mRNA进行直接检测,通过熔解曲线评价试验的特异性,以及血清样本稀释观察方法的检测下限。并且,用该方法检测2008年1月至2009年1月山东大学齐鲁医院158例结直肠癌患者,其中Ⅰ期26例、Ⅱ期53例、Ⅲ期47例和Ⅳ期32例,以及53例结直肠镜检查正常者血清循环Bmi-1 mRNA水平,采用Kruskal-Wallis H、Mann-Whitney U检验比较各组Bmi-1 mRNA表达水平,受试者工作特征曲线( ROC)分析其对结直肠癌的检测效能。结果 Bmi-1、UBC、GAPDH log值与定量循环( Cq )值间呈良好线性关系(R2=0.990、0.990、0.99,P均<0.001),扩增效率(E)分别为0.875、0.917、0.935。建立的RT-qPCR-D方法,检测Bmi-1、UBC、GAPDH mRNAs的熔解曲线峰值单一;检测下限可达1.25μl。运用该方法检测血清循环Bmi-1 mRNA水平,在结直肠癌Ⅰ期患者中为0.138(0.078-0.228),Ⅱ期患者中为0.163(0.067-0.287)、Ⅲ期患者中为0.217(0.072-0.267)、Ⅳ期患者中为0.273(0.139-0.419)以及对照者中为0.021(0.008-0.029),各组间比较差异有统计学意义(H=89.5,P<0.001)。结直肠癌各期组循环Bmi-1 mRNA水平明显高于对照组(U=58.0、287、246、72.5,P均<0.001);循环Bmi-1 mRNA在Ⅳ期患者中的水平明显高于其他各期患者(U=247、590、540,P=0.008、0.020、0.035),而在Ⅰ期、Ⅱ期、Ⅲ期患者间比较,差异无统计� Objective To establish a direct reverse transcription real-time fluorescence quantitative polymerase chain reaction ( RT-qPCR-D ) method for detecting serum circulating B cell-specific moloney murine leukemia virus integration site-1 (Bmi-1) mRNA, and analyze the levels of serum circulating Bmi-1 mRNA in colorectal cancer patients by using of this method for exploring its diagnosis value in colorectal cancer.Methods Methodology establishment.RNA was extracted from colorectal cancer HT 29 cell line, and detection standard curves of Bmi-1, ubiquitin C ( UBC), glyceraldehyde-3-phosphate dehydrogenase ( GAPDH) mRNAs were established , then the amplification efficiencies were calculated.Bmi-1 mRNA level was directly detected in serum and preparation buffer mixture , then the specificity of assay was evaluated by melting curve, and detection limit was observed through diluted serum samples.The serum circulating Bmi-1 mRNA levels were detected by ELISA in 158 cases with colorectal cancer , of which there were 26 cases of tumor node metastasis ( TNM)Ⅰstage, 53 cases of TNMⅡ, 47 cases of TNMⅢ, 32 cases of TNMⅣand 53 cases of controls with normal colonoscopy collected from January 2008 to January 2009 in Qilu Hospital of Shandong University.Comparisons of groups were determined by applying Mann-Whitney U test or Kruskal-Wallis test, and receiver operating characteristic ( ROC) curves were established to illustrate the diagnostic performance.Results The log values of Bmi-1, UBC and GAPDH showed good linear correlations with quantification cycle (Cq) values(R2 =0.990, 0.990, 0.991, all P 〈0.001), and the amplification efficiencies were 0.875, 0.917 and 0.935, respectively.Using the established RT-qPCR-D method, the peak of melting curve of Bmi-1, UBC and GAPDH mRNAs were single, the detection limit was up to 1.25μl.The levels of serum circulating Bmi-1 mRNA detected by RT-qPCR-D were 0.138 ( 0.078-0.228 ) in colorectal cancer stage Ⅰ patients, 0.163(0.067 -0.287) instage �
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2014年第9期678-682,共5页 Chinese Journal of Laboratory Medicine
基金 国家自然科学基金(81271916,81301506) 高等学校博士学科点专项科研基金(20120131110055,20130131120067) 山东省自然科学基金(ZR2013HQ063)
关键词 结直肠肿瘤 逆转录聚合酶链反应 敏感性与特异性 Colorectal neoplasms Reverse transcriptase polymerase chain reaction Sensitivity and specificity
  • 相关文献

参考文献13

  • 1Vather R, Sammour T, Kahokehr A, et al. Lymph node evaluation and long-term survival in Stage II and Stage III colon cancer: a national study[ J]. Ann Surg Oncol, 2009, 16: 585- 593. 被引量:1
  • 2汪付兵,涂建成.核酸技术在乳腺癌实验诊断中的进展[J].中华检验医学杂志,2013,36(11):978-982. 被引量:3
  • 3Zhang X, Wang C, Wang L, et al. Detection of circulating Bmi-1 mRNA in plasma and its potential diagnostic and prognostic value for uterine cervical cancer[J]. Int J Cancer, 2012, 131: 165- 172. 被引量:1
  • 4李雪峰,徐建军,张青云.荧光定量PCR检测血清微小RNA-21方法的建立及对乳腺癌诊断的初步应用[J].中华检验医学杂志,2011,34(10):920-925. 被引量:9
  • 5王传新,张欣.一种检测宫颈癌血浆Bmi-1mRNA的专用试剂盒及方法[P].中国专利:201110167829,2011-11-02. 被引量:1
  • 6Kim JH, Yoon SY, Kim CN, et al. The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced pl6INK4a/pl4ARF proteins [ J ]. Cancer Lett, 2004, 203 : 217-224. 被引量:1
  • 7He X, Dang Y, Wu CW, et al. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene [ J ]. Mol Med, 2013, 18: 1491-1498. 被引量:1
  • 8Liu YL, Jiang SX, Yang YM, et al. USP22 acts as an oncogene by the activation of BMI-l-mediated INK4a/ARF pathway and Akt pathway[J]. Cell Biochem Biophys, 2012, 62: 229-235. 被引量:1
  • 9Du J, Li Y, Li J, Zheng J. Polycomb group protein Bmil expression in colon cancers predicts the survival[ J]. Med Oncol, 2010, 27: 1273-1276. 被引量:1
  • 10Silva J, Silva JM, Garcia V, et al. RNA is more sensitive than DNA in identification of breast cancer patients bearing tumor nucleic acids in plasma[ J]. Genes Chromosomes Cancer, 2002, 35 : 375-376. 被引量:1

二级参考文献59

  • 1柯峰,吴健民,姚见儿,白艳军,郭安亮.悬浮阵列技术检测循环肿瘤细胞基因预测乳腺癌术后复发[J].中华医学杂志,2007,87(32):2257-2261. 被引量:9
  • 2Wiechmann L,Sampson M,Stempel M,et al.Presenting features of breast cancer differ by molecular subtype.Ann Surg Oncol,2009,16:2705-2710. 被引量:1
  • 3Roth C,Pantel K,Muller V,et al.Apoptosis-related deregulation of proteolytic activities andhigh serum levels of circulating nucleosomes and DNA in bloodcorrelate with breast cancer progression.BMC Cancer,2011,11:4. 被引量:1
  • 4Page K,Hava N,Ward B,et al.Detection of HER2 amplifi cation in circulating free DNA in patients with breast cancer.Br J Cancer,2011,104:1342-1348. 被引量:1
  • 5Polcher M,Ellinger J,Willems S,et al.Impact of the menstrual cycle on circulating cell-free DNA.Anti Cancer Res,2010,30:2235-2240. 被引量:1
  • 6Shaw JA,Brown J,Coombes RC,et al.Circulating tumor cells and plasma DNA analysis in patients with indeterminate early or metastatic breast cancer.Biomark Med,2011,5:87-91. 被引量:1
  • 7Dawson SJ,Tsui DW,Murtaza M,et al.Analysis of circulating tumor DNA to monitor metastatic breast cancer.N Engl J Med,2013,368:1199-1209. 被引量:1
  • 8Gevensleben H,Garcia-Murillas I,Graeser MK,et al.Noninvasive detection of HER2 amplification with plasma DNA digital PCR.Clin Cancer Res,2013,19:3276-3284. 被引量:1
  • 9Liggett TE,Melnikov AA,Marks JR,et al.Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients.Int J Cancer,2011,128:492-499. 被引量:1
  • 10Radpour R,Barekati Z,Kohler C,et al.Hypermethylation of tumor suppressor genes involved in critical regulatory pathways for developing a blood-based test in breastcancer.PLoS One,2011,6:e16080. 被引量:1

共引文献10

同被引文献36

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部